| Active substance |
Gonadotropina |
| Also known as |
Human Chorionic Gonadotropin (hCG), Follicle-Stimulating Hormone (FSH), Luteinizing Hormone (LH) |
| Blood pressure |
Can cause fluctuation, often increases |
| Chemical name |
Gonadotropins |
| Dosage (medical) |
Typically 75-300 IU, administered via injection, depending on the specific condition and treatment protocol |
| Dosage (sports) |
Not typically specified, as non-medical use is not recommended |
| Effects |
Induces ovulation in women and increases sperm production in men |
| Formula |
Variable as these are complex glycoproteins |
| Half-life |
Approximately 2-24 hours depending on specific form (e.g., FSH, LH) |
| Hepatotoxicity |
Low to none reported |
| Lab Test |
Serum levels of LH, FSH, estrogen, and testosterone can be monitored |
| Main action |
Stimulates the production of sex hormones and gamete production |
| Side effects |
Ovarian hyperstimulation syndrome, headache, fatigue, mood swings, premature puberty |
| Storage conditions |
Refrigerate, protect from light |
| Substance class |
Hormones |
| Trade name |
Examples include Pregnyl, Ovidrel, Follistim |
| Use in sports |
Mainly for performance enhancement through increased testosterone levels (abuse suspected) |
| Water Retention |
Yes, can cause significant water retention |
| Active ingredient, IU |
1000, 1500 |
| Release form |
Vial |
| 1 Vial, IU |
1000, 1500 |
| Vials in the package, pcs |
5 |
| Manufacturer |
FGYP Pianta endocrina di Mosca |
| Packing |
Vial 1000 IU, Vial 1500 IU, Packing (5 bottles 1500 IU), Packing (5 bottles 1000 IU) |
